STOCKHOLM--(BUSINESS WIRE)--Regulatory News: AbSorber, part of Allenex (STO:ALNX) group, focusing on antibody detection before transplantation has received US patent protection for its cross match-test XM-ONE®. The patent, with the title Methods of Donor Specific Crossmatching, was granted by the US Patent and Trademark Office. AbSorber has previously approved patent for XM-ONE® in other regions including the European Union, India, Australia and Canada. “The fact that our patent was approved in the U.S. is of great value to us. It is a strong confirmation that the product is unique and has a high degree of innovation. Currently we are working hard in collaboration with leading laboratories in the U.S. to establish clinical use of the product”, said Anders Karlsson, CEO Allenex.
